Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Upstream Bio (UPB) Return on Sales (2023 - 2025)

Upstream Bio (UPB) has 2 years of Return on Sales data on record, last reported at 53.11% in Q3 2025.

  • For Q3 2025, Return on Sales fell 2317.0% year-over-year to 53.11%; the TTM value through Sep 2025 reached 49.11%, down 2742.0%, while the annual FY2024 figure was 30.47%, 1537.0% down from the prior year.
  • Return on Sales reached 53.11% in Q3 2025 per UPB's latest filing, roughly flat from 53.27% in the prior quarter.
  • Across five years, Return on Sales topped out at 21.48% in Q1 2024 and bottomed at 53.27% in Q2 2025.